Flosonics Secures Strategic Investment from Denka

Flosonics Medical has secured a strategic investment from Denka Co., Ltd., a Tokyo-based global specialty chemicals company with a growing healthcare and diagnostics business, made through Denka’s corporate venture capital fund operated with Pegasus Tech Ventures. The investment connects FloPatch, their wearable, wireless Doppler ultrasound, to Denka’s broader expansion into digital health. For our team, this support helps accelerate the work that matters most, putting better hemodynamic assessment in the hands of more clinicians caring for critically ill patients, including those with sepsis.

Flosonics Medical is an alumnus of our BDSP™, CAAP®, EAHN™, HealthMINT™, LSCTC Centre of Excellence and WiHI programs, and presented at the OBIO® Investment Summit.